Kaizaki-Mitsumoto, A; Noguchi, N; Yamaguchi, S; Odanaka, Y; Matsubayashi, S; Kumamoto, H; Fukuhara, K; Funada, M; Wada, K; Numazawa, S. Three 25-NBOMe-type drugs, three other phenethylamine-type drugs (25I-NBMD, RH34, and escaline), eight cathinone derivatives, and a phencyclidine analog MMXE, newly identified in ingredients of drug products before they were sold on the drug market Forensic Toxicol., 1 Jan 2016, 34 (1), 108–114. 854 kB. https://doi.org/10.1007/s11419-015-0293-6 #12 MS,NMR
EMCDDA. New drugs in Europe, 2017, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 Aug 2017. 672 kB. #19
Sasaki, R; Kato, M; Matsumoto, T; Udagawa, A; Matsuzaki, R. A method for identifying designer drugs of synthetic cathinones JCCL, 1 Dec 2015, (55), 17–41. 663 kB. #5 Japanese, English abstract MS,NMR,IR,UV
2-FDEC · 2-Fluoro-N,N-diethylcathinone
2-FPMC · 2-Fluoro-N-propyl-N-methylcathinone
3-FDEC · 3-Fluoro-N,N-diethylcathinone
3-FPMC · 3-Fluoro-N-propyl-N-methylcathinone
4-FDEC · 4-Fluoro-N,N-diethylcathinone
4-FPMC · 4-Fluoro-N-propyl-N-methylcathinone
3-F-TMPM · 3′-Fluoro-5,5-dimethylphenmetrazine
4F-Hexedrone · 4′-Fluoro-2-(methylamino)hexanophenone